26 reports

China’s demand for Allergy Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Allergy Drug
  • China
  • Industrial Production
  • Labour Force

The Asia Pacific allergy treatment market is expected to reach US$ 9,991.64 million by 2028 from US$ 5,662.06 million in 2020; it is estimated to grow with a CAGR of 7.4% from 2021 to 2028. The growth of the market is attributed to increasing adoption of immunotherapy in allergy treatment, and developments in food allergy treatments. However,...

  • Allergy Drug
  • APAC
  • Drug Approval
  • Allergy Prevalence

The global allergy treatment market is expected to reach US$ 35,812.33 million by 2028 from US$ 21,160.92 million in 2020; it is estimated to grow at a CAGR of 6.9% from 2020 to 2028. Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments are the factors driving the global allergy treatment...

  • Allergy Drug
  • APAC
  • Europe
  • World
  • Africa
  • Middle East
  • Central America
  • Allergy Prevalence
  • Drug Approval

The North America allergy treatment market is expected to reach US$ 10,940.67 million by 2028 from US$ 6,646.04 million in 2020; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the market is attributed to increasing adoption of immunotherapy in allergy treatment, and developments in food allergy treatments. However,...

  • Allergy Drug
  • North America
  • Drug Approval
  • Health Expenditure

The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments....

  • Allergy Drug
  • Europe
  • Drug Approval
  • Allergy Prevalence

Abstract: - Global Anti-Allergy Drugs Market to Reach $39.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Allergy Drugs estimated at US$24.8 Billion in the year 2020, is projected to reach a revised size of US$39.3 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027....

  • Allergy Drug
  • World
  • China
  • United States

Abstract: - Global Allergy Treatment Market to Reach $38.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Allergy Treatment estimated at US$27.1 Billion in the year 2020, is projected to reach a revised size of US$38.4 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027....

  • Allergy Drug
  • Food Allergy
  • World
  • China
  • United States

The allergy treatment market was valued at USD 17,439 million in 2020, and it is expected to reach USD 24,329.11 million by 2026, registering a CAGR of 6.48% during the forecast period. With the onset of the COVID-19 pandemic, a large section of people globally was struggling with chronic respiratory issues, such as respiratory allergies,...

  • Allergy Drug
  • World
  • Allergy Prevalence
  • Asthma Prevalence

Global Allergy Rhinitis Drugs Market 2021-2025 The analyst has been monitoring the allergy rhinitis drugs market and it is poised to grow by $ 2.96 bn during 2021-2025, progressing at a CAGR of about 4% during the forecast period. Our report on allergy rhinitis drugs market provides a holistic analysis, market size and...

  • Allergy Drug
  • Allergy
  • World

The major factors for the growth of the allergy treatment market include the increasing burden of various types of allergies, increased investment by the manufacturers on the development of novel allergic treatments and rising importance for self-medication. The rising cases of allergies are expected to increase the demand of allergy...

  • Allergy Drug
  • Food Allergy
  • Therapy
  • Allergy Immunotherapy
  • Europe
  • APAC
  • Africa
  • South Africa
  • Allergy Prevalence
  • Asthma Prevalence

This study focuses on China’s Allergy Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one...

  • Allergy Drug
  • Pharmaceutical
  • China
  • Employment Costs
  • Pharmaceutical Production

This study focuses on China’s Allergy Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers...

  • Allergy Drug
  • China
  • Labour Force
  • Industrial Production

The automated storage and retrieval system market in SAM is expected to grow from US$ 200.67 million in 2020 to US$ 364.46 million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028. Structured management of redundant warehouse processes is also bolstering the growth of the industry. Storage and retrieval tasks were traditionally...

  • Allergy Drug
  • Central America
  • Drug Approval
  • Allergy Prevalence

The drinking water adsorbents market in the MEA is expected to grow from US$ 58.49 million in 2019 to US$ 72.61 million by 2027; it is estimated to grow at a CAGR of 2.8% from 2020 to 2027. The market in SAM is expected to grow from US$ 44.81 million in 2019 to US$ 57.25 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020...

  • Allergy Drug
  • Africa
  • Middle East
  • Drug Approval
  • Allergy Prevalence

Allergic Rhinitis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H2 2020, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape. Allergic rhinitis is an allergic reaction...

  • Respiratory Disease
  • Allergy Drug
  • World
  • Pharmaceutical Registrations
  • Medicine Use

This study covers the world outlook for allergy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Allergy Drug
  • World
  • Gross Domestic Product
  • Disposable Income

Allergic Rhinitis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H1 2020, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape. Allergic rhinitis is an allergic reaction...

  • Respiratory Disease
  • Allergy Drug
  • World
  • South Korea
  • South Africa
  • Medicine Use
  • Pharmaceutical Registrations

Rhino-Conjunctivitis - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Rhino-Conjunctivitis - Pipeline Review, H2 2019, provides an overview of the Rhino-Conjunctivitis (Ophthalmology) pipeline landscape. Rhinitis is characterized by one...

  • Allergy Drug
  • Respiratory Disease
  • World
  • Medicine Use

Allergy Treatment Market by Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs and Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others): Global Opportunity Analysis...

  • Allergy Drug
  • World
  • APAC
  • Allergy Prevalence
  • Biosimilar Penetration Rate

Rhino-Conjunctivitis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rhino-Conjunctivitis - Pipeline Review, H1 2018, provides an overview of the Rhino-Conjunctivitis (Ophthalmology) pipeline landscape. Rhinitis is characterized...

  • Allergy Drug
  • Respiratory Disease
  • World
  • Medicine Use
  • Drug Approval

This study covers the latent demand outlook for allergy drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state...

  • Allergy Drug
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for allergy drugs across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or...

  • Allergy Drug
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for allergy drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to...

  • Allergy Drug
  • China
  • Disposable Income
  • Purchasing Power Parity

Global Allergy Treatment Market: Overview The allergy treatment market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on new treatment development for allergy specific drugs, and increasing prevalence of allergic diseases. The market overview section...

  • Allergy Drug
  • World
  • Allergy Prevalence

- The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021. - Treatments market is expected to grow from $33.4 billion in 2016 to $44.4 billion...

  • Diagnostics
  • Healthcare
  • Therapy
  • Allergy Drug
  • Allergy
  • World
  • Asia
  • Health Expenditure
  • Urban Population

Hypersensitivity - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypersensitivity, complete with...

  • Allergy
  • Allergy Drug
  • Respiratory Disease
  • World
  • Dropout Rate
  • Drug Approval